Linde Considers More U.S. Asset Sales for Praxair Deal
(Bloomberg) -- Linde AG is considering the sale of additional assets in the U.S. that would mark a near-complete retreat from industrial gas operations in the country and a last-ditch attempt to salvage its $47 billion merger with Praxair Inc., according to people familiar with matter.
The decision to dispose of the onsite and specialty gas businesses hasn’t been finalized and would still need approval from Linde’s supervisory board, said the people, who asked not to be named as the deliberations are private. CVC Capital Partners and Messer Group GmbH would be willing to buy the assets, one of the people said.
Linde has already agreed to sell a $3.3 billion package of North American assets -- including Linde’s U.S. bulk business -- to CVC and Messer. The additional businesses to be sold include plants built at oil refineries to supply hydrogen to make low-sulfur fuel. The merged entity would still have Praxair assets in the country.
A spokesman for Linde declined to comment as did a representative of CVC. Praxair spokeswoman Lisa Esneault didn’t respond to a request for comment and Messer wasn’t immediately available.
The move to put even more businesses up for sale comes as the suppliers of gases like oxygen and nitrogen for factories and hospitals attempt to salvage a deal that has been at least two years in the making and now faces the prospect of collapse. The companies were caught off guard by a notice from the Federal Trade Commission in the U.S. to sell more assets in order to gain antitrust approval even after they had already agreed to roughly $9 billion worth of disposals in Europe and North America.
Linde’s warning Sunday that the FTC request has resulted in a “higher probability” that asset sales will exceed a limit set by the companies sent their shares tumbling on Monday. The German and U.S. suppliers were already under pressure to meet an Oct. 24 deadline for approvals for the deal.
The shares pared declines after the Bloomberg report, trading 7.5 percent lower at 194.50 euros at the close in Frankfurt. Praxair’s stock fell 3.8 percent to $157.96 at the close in New York.
As part of their agreement to combine, the companies set limits on the assets they would be willing to jettison in return for regulatory clearance. Under their deal, the units to be sold must have annual sales of less than 3.7 billion euros ($4.3 billion) or income before interest, taxes, depreciation and amortization of less than 1.1 billion euros. The latest requests from U.S. regulators are “more onerous than previously expected,” said Linde, which generates about 23 percent of its revenue in the country.
Before the FTC request, the companies reached agreements to shed assets. Last month, Linde announced the sale of North American businesses with combined 2017 revenue of about $1.7 billion that included Linde’s U.S. bulk business and operations in Brazil, Canada and Colombia. A little more than a week earlier, Linde and Praxair agreed to sell a raft of industrial-gas plants in Europe to a Japanese competitor. They indicated at the time that additional sales may be necessary to get final approval from regulators.
Linde’s U.S. onsite business generates about 1 billion euros of sales and is probably the new point of contention with the FTC, JPMorgan analyst Jeffrey Zekauskas said in a note. Selling the entire division would put total planned divestitures at or above the deal limit, but that’s a “low” probability, he said. Rather, a portion of the unit is likely to be sold, he said.
“The transaction continues to have a good chance of being completed,” Zekauskas said in the note.
The companies have already faced a rough ride during a European antitrust review of their deal, which would see the merged entity bear the Linde name and be listed in New York and Frankfurt. They agreed to sell the European assets to Taiyo Nippon Sanso Corp.
Under terms of the tie up, Praxair Chief Executive Officer Steve Angel and Linde Chairman Wolfgang Reitzle will keep their titles and the board and management will come from each of the companies. The new holding company will be incorporated in Ireland and board meetings will be mostly be held in the U.K., Linde has said. Corporate functions will be split between Munich and Danbury, Connecticut, where Praxair is based.
©2018 Bloomberg L.P.